Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05780775 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Lipid Balance in Adult Sickle Cell Patients

Study acronym: HDL2
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Nov 30, 2028 to Nov 30, 2027v2 Show 4 more changesShow less
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: estimated 350 to confirmed 116
    • Study sites: 2 to 1
    • Study arms: 0 to 1
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to describe and/or searches for, in cohorts of adult sickle cell anemia (SCA) and SC sickle cell patients living in the French West Indies and followed by SCD Reference and Competence Centers: 1-lipids profiles and associations at steady state with occurrence of sickle cell disease (SCD) complications, 2-lipids profile evolution during and after prospective acute complications (vasoocclusive crises (VOC) and priapism), 3-lipids profile variation (inter /intra individuals) during 4 prospective years, 4- Genetic primary modulators of SCD complications, 5- insulin resistance (HOMA), free fatty acids and glycerol dosages, 6- lipids enzymes, lipidome and functionality of HDL in sub-groups of SCD population.
Trial Details
NCT Number NCT05780775
Lead Sponsor Centre Hospitalier Universitaire de la Guadeloupe
Collaborators: Direction Générale de l'Offre de Soins
Conditions
(from sponsor)		 Sickle Cell Disease, Dyslipidemia, Complication
Related terms Anemia, Sickle Cell, Dyslipidemias, Priapism, Pulmonary Arterial Hypertension, Vaso-Occlusive Crises
Enrollment 116 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov